Skip to main content

Table 2 Blood gas and serum biochemical factors in four stages of HFMD (\( \overline{x} \) ± s)

From: B-type brain natriuretic peptide as a measure of the severity of hand-foot-mouth disease: a case-control study

Indexes

Phase I

Phase II

Phase III

Phase IV

n

30

29

13

11

Lac (mmol/L)

1.3 (1.0,1.93)

1.1 (1.0,1.6)

2.1 (1.55,3.05)

2.3 (1.9,4.3)

Glu (mmol/L)

5.8 (4.68,6.55)

5.99 (5.15,6.90)

11.2 (7.90,14.25)

12.2 (9.7,19.9)

PaO2/FiO2

453.57 (416.07,487.50)

421.43 (408.93,460.71)

228.75 (136.63,408.93)

135.0 (80.36,256.88)

BNP (pmol/L)

5.8 (4.68,6.55)

3.42 (1.84,6.95)

54.78 (16.74,123.74)

25.82 (8.48,44.83)

CO (L/min)

2.735 ± 0.681

2.660 ± 0.621

2.289 ± 0.477

2.692 ± 0.704

WBC(×109/L)

10.697 ± 2.501a,c

10.111 ± 2.617a,c

15.183 ± 5.123a

19.682 ± 6.313c

  1. a p < 0.05, comparison of Phase IV group to other groups
  2. b p < 0.01, comparison of Phase IV group to other groups
  3. c p < 0.05, comparison of Phase III group to other groups